Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Sahyadri Super Speciality Hospitalপুনে, মহাৰাষ্ট্ৰদিশ ↗
Bhakti Vedanta Hospital and Research Instituteথানে, মহাৰাষ্ট্ৰদিশ ↗
Fortis Hospitalনতুন দিল্লী, নেচনেল কেপিটেল টেৰিটৰী অফ দিল্লীদিশ নিৰ্দেশ ↗
Rajiv Gandhi Cancer Institute And Research Centreনৰ্থ ৱেষ্ট দিল্লী, নেচনেল কেপিটেল টেৰিটৰী অফ দিল্লীদিশ নিৰ্দেশ ↗
Sparsh Hospitals & Critical Care (P) Ltdভুবনেশ্বৰ, ওড়িশাদিশ নিৰ্দেশ ↗
Basavatarakam Indo American Cancer Hospital & Research Instituteহায়দৰাবাদ, তেলেংগানাদিশ ↗
Chittaranjan National Cancer Instituteকলকাতা, পশ্চিমবংগদিশ ↗
ৰেজিষ্ট্ৰীৰ সাৰাংশ (কাৰিকৰী)
This study is being done to find out if a new medicine called PF-08634404, when given with chemotherapy, works better than the present standard treatment (pembrolizumab with chemotherapy) for adults with a type of lung cancer called non-small cell lung cancer (NSCLC) that is either locally advanced (spread to nearby tissues) or has spread to other parts of the body.
To join the study, participants must meet the following conditions:
* Be 18 years or older.
* Have locally advanced (Stage IIIB/IIIC) or metastatic (Stage IV) squamous or non-squamous NSCLC.
* Is not a candidate for complete surg…
